跳至主要内容
临床试验/NCT07538544
NCT07538544尚未招募1 期

MCE Molecular Imaging in Myocarditis

University of Virginia1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年9月15日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
尚未招募
入组人数
30
试验地点
1
主要终点
Diagnostic accuracy for presence/absence of ICI Myocarditis

研究概览

简要总结

Inflammation of the heart (myocarditis) is a serious condition that can cause heart failure, abnormal heart rhythms, cardiac arrest, and death. Rapid diagnosis of this condition is key to reversing it. The purpose of this study is to determine whether myocarditis such as that which occurs with viral illness, autoimmune conditions, or certain therapies (i.e. immune checkpoint inhibitors) can be diagnosed using a new form of ultrasound imaging of the heart (echocardiography) that uses a contrast agent that is targeted to inflammation (Sonazoid).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years of age
  • At least two of the following manifestations of myocarditis:
  • new or suspected new high-sensitivity troponin >3 times upper limit of normal
  • new or suspected new LV dysfunction with LVEF <50% or any segmental wall motion abnormality in the absence of prior ischemic event
  • ECG changes consistent with myocarditis defined as either diffuse ST elevation or ST-T abnormalities that are documented to be new,
  • unexplained severe ventricular arrhythmias,
  • Cardiac MR evidence for myocarditis
  • Predisposing condition or therapy associated with heightened risk of acute myocarditis (i.e. SARS-CoV-2, Parvovirus, Immune checkpoint inhibitors)

排除标准

  • Inability to obtain consent
  • High pre-test likelihood for ACS based on ECG and history
  • Pregnancy or planned pregnancy
  • Lactation
  • Allergy to ultrasound contrast agents or eggs
  • Treatment with potent immunosuppressive therapy beyond corticosteroids
  • Conditions associated with inflammatory myopathy (SLE, giant cell myocarditis, sarcoidosis, etc.)

研究组 & 干预措施

Patients with suspected Myocarditis

Experimental

Patients with any degree of suspicion for myocarditis based on symptoms, lab tests, ECG, or imaging tests.

干预措施: Myocardial contrast echocardiography molecular imaging for inflammation (Diagnostic Test)

结局指标

主要结局

Diagnostic accuracy for presence/absence of ICI Myocarditis

时间窗: 3 months

The ability of of MCE molecular imaging with Sonazoid to diagnose ICI myocarditis will be determined by comparing to a gold standard (either cardiac MRI or myocardial biopsy).

Diagnostic accuracy for presence/absence of Myocarditis

时间窗: 3 months

The ability of of MCE molecular imaging with Sonazoid to diagnose myocarditis will be determined by comparing to a gold standard (either cardiac MRI or myocardial biopsy).

次要结局

  • Response to therapy(3 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jonathan Lindner, MD

Professor of Medicine

University of Virginia

研究点 (1)

Loading locations...

相似试验